|
[1]
|
Varbo, A. and Nordestgaard, B.G. (2014) Remnant Cholesterol and Ischemic Heart Disease. Current Opinion in Lipid-ology, 25, 266-273. [Google Scholar] [CrossRef]
|
|
[2]
|
Mach, F., Baigent, C., et al. (2020) 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41, 111-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chait, A. and Goldberg, I. (2017) Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions. Current Diabetes Reports, 17, Article No. 112. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Nakamura, T., et al. (2005) Remnant Lipo-proteinemia Is a Risk Factor for Endothelial Vasomotor Dysfunction and Coronary Artery Disease in Metabolic Syn-drome. Atherosclerosis, 181, 321-327. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Nordestgaard, B.G., Langlois, M.R., et al. (2020) Quan-tifying Atherogenic Lipoproteins for Lipid-Lowering Strategies: Consensus-Based Recommendations from EAS and EFLM. Atherosclerosis, 294, 46-61. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Quispe, R., et al. (2021) Remnant Cholesterol Predicts Cardiovascular Disease beyond LDL and ApoB: A Primary Prevention Study. European Heart Journal, 42, 4324-4332. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Doi, T., et al. (2022) Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction. Journal of the American College of Cardiology, 79, 2383-2397. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Castaner, O., et al. (2020) Remnant Cholesterol, Not LDL Cholesterol, Is Associated with Incident Cardiovascular Disease. Journal of the American College of Cardiology, 76, 2712-2724. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Goliasch, G., et al. (2015) Premature Myocardial Infarction Is Strongly Associated with Increased Levels of Remnant Cholesterol. Journal of Clinical Lipidology, 9, 801-806. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Nguyen, S.V., et al. (2014) High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment after Acute Coronary Syndrome. Circulation Journal, 78, 2492-2500. [Google Scholar] [CrossRef]
|
|
[11]
|
Qin, Z., Zhou, K., Li, Y., et al. (2019) Remnant Lipo-proteins Play an Important Role of In-Stent Restenosis in Type 2 Diabetes Undergoing Percutaneous Coronary Interven-tion: A Single-Centre Observational Cohort Study. Cardiovascular Diabetology, 18, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Schaefer, E.J., McNamara, J.R., Shah, P.K., Nakajima, K., et al. (2002) Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framing-ham Offspring Study. Diabetes Care, 25, 989-994. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhao, Q., Zhang, T., et al. (2020) Prognostic Impact of Estimated Remnant-Like Particle Cholesterol in Patients with Differing Glycometabolic Status: An Observational Cohort Study from China. Lipids in Health and Disease, 19, Article No. 179. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Shao, Q., Yang, Z., Wang, Y., et al. (2022) Elevated Remnant Cholesterol Is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome. Journal of Atherosclerosis and Thrombosis, 29, 1808-1822. [Google Scholar] [CrossRef] [PubMed]
|